spacer
home > ebr > summer 2003 > mass-based fraction collection of crude synthetic peptides in analytical and preparative scale for cancer treatment
PUBLICATIONS
European Biopharmaceutical Review

Mass-Based Fraction Collection of Crude Synthetic Peptides in Analytical and Preparative Scale for cancer treatment

Synthetic peptides become more and more important as drug candidates in the treatment of a variety of diseases. A particular therapeutic focus for synthetic peptides is cancer treatment (1, 2). In order to keep pace with the growing number of newly synthesised peptides, peptide purification should not represent a bottleneck in the drug discovery process. Since the target masses of synthetic peptides are well known, mass-based fraction collection represents an efficient technique for their purification. In contrast to fraction triggering with less specific detectors, employing a mass selective detector only leads to the purification of the target mass in each run. Consequently, it is not necessary to pick out the compound of interest from a series of redundant fractions.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Ralf Moritz, Application Chemist at Agilent Technologies, and Nicola O'Reilly at Cancer Research UK
Ralf Moritz studied Chemistry at Gerhard Mercator University, Germany, before moving to McMaster University in Canada for a year in 1993.

He completed his PhD thesis at Robert Koch-Institute, Berlin in 2000 before undertaking research work at the Max Delbrück Centrum for Molecular Medicine, Berlin. Since 2001 Ralf has been an Application Chemist at Agilent Technologies, Germany.


Nicola O'Reilly received a BSc (Hons) in Chemistry from Southampton University in 1987. She then joined Cancer Research UK (then Imperial Cancer Research Fund), running the peptide synthesis laboratory.

In 1994 Nicola completed a master's degree in Biochemistry at King's College London. In October 1999 she set up a new 2D gel electrophoresis facility and in July 2000 she took over the ICRF Protein Isolation Service. After the formation of Cancer Research UK she opened up peptide synthesis and protein isolation to new Cancer Research UK clients.


spacer
Ralf Moritz
spacer
spacer
spacer
Nicola O'Reilly
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

2012 BIO International Convention

18-21 June 2012, Boston, Massachusetts

Connect, partner and innovate at the 2012 BIO International Convention, June 18-21, Boston, Mass. Network with 15,000+ global biotech leaders in the BIO Business Forum, Exhibition and Programme.
More info >>

 
News and Press Releases

Delta Industrial Services to display at Pharmapack

Delta Industrial Services, a leader in web converting and packaging innovation, will be showcasing some of their recent developments in pharmaceutical manufacturing and pouching.
More info >>

 

 

Buy Atrovent Online no prescription Buy Symbicort Online no prescription Buy Flovent Online no prescription Buy Flonase Online no prescription Buy Rhinocort Online no prescription Buy Allegra Online no prescription Buy Advair Online no prescription Buy Combivent Online no prescription Buy Astelin Online no prescription Buy Spiriva Online no prescription Buy Ventolin Online no prescription
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.